Altus Wealth Management’s AbbVie ABBV Stock Holding History

Altus Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,875	Closed	-$393K	–	31
2025 Q1	$393K	Hold	1,875	–	–	0.18%	29
2024 Q4	$333K	Hold	1,875	–	–	0.15%	31
2024 Q3	$370K	Hold	1,875	–	–	0.17%	29
2024 Q2	$322K	Hold	1,875	–	–	0.15%	32
2024 Q1	$341K	Hold	1,875	–	–	0.18%	28
2023 Q4	$291K	Buy	1,875 +380	+25%	+$55.4K	0.17%	32
2023 Q3	$223K	Sell	1,495 -27	-2%	-$3.96K	0.15%	34
2023 Q2	$205K	Sell	1,522 -6	-0.4%	-$880	0.16%	30
2023 Q1	$244K	Buy	1,528 +33	+2%	+$5.04K	0.2%	27
2022 Q4	$242K	Hold	1,495	–	–	0.21%	23
2022 Q3	$201K	Hold	1,495	–	–	0.17%	31
2022 Q2	$229K	Hold	1,495	–	–	0.18%	32
2022 Q1	$242K	Buy	+1,495	New	+$217K	0.17%	32

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Altus Wealth Management's ABBV Position: Q2 2025 in Review

Altus Wealth Management sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,875 shares — an estimated $393K sold.

Altus Wealth Management first reported a position in ABBV in Q1 2022 and held it in 13 quarters. The position peaked at $393K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Altus Wealth Management reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
Altus Wealth Management sold 1,875 AbbVie shares in Q2 2025, an estimated $393K.
Altus Wealth Management first reported a position in AbbVie in Q1 2022 and held it in 13 quarters.
Altus Wealth Management's AbbVie position peaked at $393K in Q1 2025.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Altus Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.